Novartis AG (TSX:NVS)
27.49
-0.31 (-1.12%)
Sep 18, 2026, 2:46 PM EST
Novartis AG Market Cap
Novartis AG has a market cap or net worth of CAD 372.21 billion as of September 18, 2026. Its market cap has increased by 13.85% in one year.
Market Cap
372.21B
Enterprise Value
429.67B
Revenue
80.51B
Ranking
n/a
PE Ratio
20.55
Stock Price
27.49
ChartMarket Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 181.47B to 372.21B, an increase of 105.11%. That is a compound annual growth rate of 2.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 372.21B | 2.25% |
| Dec 30, 2025 | 364.01B | 29.38% |
| Dec 30, 2024 | 281.35B | 2.84% |
| Dec 29, 2023 | 273.59B | 3.96% |
| Dec 30, 2022 | 263.17B | 4.77% |
| Dec 30, 2021 | 251.19B | -8.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FLUENT | 17.85M |
| Refined Energy | 9.86M |
| LIR Life Sciences | 5.73M |
| Promino Nutritional Sciences | 5.38M |
| Nirvana Life Sciences | 1.15M |
| Else Nutrition Holdings | 978.40K |
| EGF Theramed Health | 638.92K |
| Digicann Ventures | 240.55K |